Skip to content

Duramesh versus suture for prevention of port-site hernia after keyhole surgery

A prospective single-centre double-blind randomised controlled trial of Duramesh versus conventional suture closure for laparoscopic periumbilical trocar sites

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14473961
Enrollment
250
Registered
2025-04-14
Start date
2025-06-09
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duramesh versus conventional suture closure for laparoscopic periumbilical trocar sites Surgery

Interventions

TROCAR is a single-centre, parallel arm, randomised controlled trial of Duramesh versus conventional suture, with blinding of patients and outcome assessors at primary outcome assessment. The aim is t

Sponsors

Croydon Health Services NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. 18 years or older. 2. Able to provide written informed consent to participation, without barriers that might prevent follow-up. 3. Any laparoscopic procedure pertaining to the domain of general surgery, requiring periumbilical incision at the linea alba for trocar insertion 10mm or greater. 4. Extraction sites acceptable up to a maximum of 3 cm. 5. Concurrent umbilical hernia if camera port inserted through the defect with subsequent primary repair without planar mesh. 6. Hernia at a remote site from port incisions e.g. concurrent inguinal hernia. 7. Previous abdominal surgery, except for the condition specified in exclusion criteria below.

Exclusion criteria

Exclusion criteria: 1. Lack of capacity to consent to trial participation. 2. Procedures where placement of a periumbilical trocar 40.

Design outcomes

Primary

MeasureTime frame
The cumulative occurrence of trocar-site hernia over 2 years, measured using ultrasound scan at 3 months, 1 year and 2 years

Secondary

MeasureTime frame
1. Surgical site occurrence within 90 days measured using physical examination 2. Reoperation within 90 days measured using data collected from patient medical records at one timepoint 3. Mortality within 90 days measured using data collected from patient medical records at one timepoint 4. Length of hospital stay in days measured using data collected from patient medical records at one timepoint 5. Patient reported quality of life (QoL) measured using the Modified EuraHS-QoL score and Modified Carolinas Comfort Scale at 3 months, 1 year and 2 years

Countries

England, United Kingdom

Contacts

Public ContactLawrence Nip
l.nip@nhs.net+44 (0)7840059436

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026